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Abstract
Background: False-positive radioiodine (RAI) uptake related to chronic sinusitis and mucocele has only rarely been
reported in patients with differentiated thyroid cancer (DTC) even with the recent use of single photon emission
tomography with computed tomography (SPECT/CT) acquisition. No other etiology of sinus RAI uptake has been
mentioned to date.
Objectives: We report five cases of DTC patients with sinus RAI uptake on post-RAI scintigraphy. SPECT/CT clearly
localized RAI uptake either in the sphenoid, the maxillary or the frontal sinus and highly suspected mucosal thickening
in four patients and sinus aspergilloma in one patient.
Conclusion: These data confirm the possibility of false-positive sinus RAI uptake, provide a new cause of such benign
uptake, i.e. sinus aspergilloma, and demonstrate the clinical relevance of head and neck SPECT/CT acquisition in
the diagnosis of such uptake. Nuclear medicine physicians should be aware of this pitfall when interpreting
post-RAI scintigraphy.
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Background
False-positive radioiodine (RAI) uptake in chronic frontal
sinusitis was reported once in a patient with differentiated
thyroid cancer (DTC) [1] and in mucocele [2] twenty years
ago using planar imaging. Although single photon emis-
sion tomography with computed tomography (SPECT/
CT) neck acquisition is commonly used in both diagnostic
[3] and post-therapeutic settings [4–7], there is still no
other published report of RAI uptake in sinuses, especially
in the maxillary or sphenoid ones. Furthermore, no cause
other than chronic sinusitis or mucocele has evoked to
explain sinus RAI uptake. We report here several cases of
DTC patients showing RAI uptake in various sinuses
(frontal, maxillary or sphenoid sinus), most of them
being related to sinus mucosal thickening and one to a
pathologically confirmed aspergilloma in a maxillary





A 61-year-old woman with papillary thyroid cancer
(pT1b N0 Mx) was referred to our department in August
2010 for RAI ablation. Whole-body scan (WBS) with neck
and thorax SPECT/CT (Fig. 1) was performed five days
after administration of 4110 MBq (111 mCi) of RAI after
recombinant human thyrotropin (rhTSH) stimulation.
Stimulated thyroglobulin (Tg) was very low at 0.1 ng/ml
without serum Tg antibodies (TgAb). WBS depicted an
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RAI focus in the nose related to nasal RAI excretion and a
left-sided moderate uptake, also suggesting physiological
excretion. Interestingly, SPECT/CT showed that the latter
uptake was located in the sphenoid sinus with mucosal
thickening. The patient had no symptoms. Sinus muco-
sal thickening had disappeared on the CT scan control




A 51-year-old woman with a 15-mm papillary thyroid
cancer with microscopic extrathyroid extension and
central node involvement (pT3 N1a Mx) was referred
for RAI ablation in January 2015. She was given
3570 MBq (96 mCi) of RAI after rhTSH. The stimulated
Tg level was 0.3 ng/ml in the presence of serum TgAb.
Five days after treatment, WBS evidenced focal RAI up-
take in the right part of the skull. SPECT/CT acquisition
ruled out bone metastasis and showed this uptake in the
right frontal sinus to be associated with mucosal thick-
ening (Fig. 2). The patient had no symptoms and was
disease-free at the last visit in October 2016.
Case 3
Frontal sinus
An 81-year-old woman with a papillary thyroid cancer with
lymph node involvement and microscopic extrathyroid
Fig. 1 Planar acquisition (anterior view, Panel a), fused (Panel d) and CT (Panel e) images of SPECT/CT acquisition displaying RAI uptake in the left
sphenoid sinus with mucosal thickening on CT scan slices (blue arrow). RAI uptake is also present in the nose (Panels a, b and c, red arrow)
Fig. 2 Planar acquisition (anterior view, Panel a), fused (Panel b) and CT (Panel c) images of SPECT/CT acquisition displaying RAI uptake in the
right part of the frontal sinus with mucosal thickening on CT scan slices (red arrow). RAI uptake is also visible in the nose (Panels a, d and e, blue arrow)
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extension (pT3 N1b Mx) was given 3681 MBq (99 mCi) of
RAI in September 2015. The stimulated Tg level was
67 ng/ml. Post-ablation WBS depicted a faint RAI uptake
in the anterior right part of the skull. SPECT/CT acquisi-
tion showed that this uptake was related to mucosal thick-
ening in the frontal sinus (Fig. 3). For the sake of
comparison, an example of a bone metastasis of the skull
which was faintly RAI-avid and well depicted by SPECT/
CT acquisition is presented in Fig. 4. Three months after
RAI ablation, Tg level was at 22 ng/ml on levothyroxine.
18-Fluorodeoxyglucose positron emission tomography with
computed tomography (18 F-FDG PET/CT) was per-
formed in October 2016 and did not show any abnormal




A 49-year-old woman was referred for RAI ablation in
April 2014 two months after total thyroidectomy for a
6-cm Hurtle cell carcinoma. She was given 3770 MBq
(102 mCi) of RAI after rhTSH stimulation. The stimu-
lated Tg level was low at 0.3 ng/ml without serum
TgAb. WBS performed five days after treatment showed
a right-sided moderate focus close to the nose suggest-
ing physiologic excretion. On SPECT/CT this focus
was clearly located in the right maxillary sinus, which
showed mucosal thickening. SPECT/CT also revealed a
faint uptake in the left maxillary sinus which was not
seen on WBS (Fig. 5). The patient had no symptoms
and was disease-free at the last visit in February 2016.
Case 5
Maxillary sinus
A 38-year-old woman with a pT3 N1b M0 papillary
thyroid cancer treated six years before by surgery and
RAI ablation presented with an increased serum Tg level
at 20 ng/ml on levothyroxine. Neck ultrasound examin-
ation did not show any abnormal lymph nodes. After a
multidisciplinary staff meeting, she was given a second
RAI treatment after rhTSH in June 2014, 1820 MBq
(49 mCi). Stimulated Tg level was 61 ng/ml without
serum TgAb. WBS performed two days after RAI ad-
ministration depicted an intense focal uptake in the left
part of the face which was not present on the post-
ablation WBS in August 2008 (Fig. 6). Complementary
head and neck SPECT/CT ruled out a bone lesion and
showed that RAI uptake was located in the left
Fig. 3 Planar acquisition (anterior view, Panel a), CT (Panel b) and fused (Panel c) images of SPECT/CT acquisition displaying a faint RAI uptake in
the right part of the frontal sinus with mucosal thickening on CT scan slices (blue arrow)
Fig. 4 A 56-year-old male patient complained of back pain related to a lytic bone metastasis which led to the discovery of a follicular thyroid
cancer. Post-ablation scintigraphy in March 2012 evidenced an intense RAI uptake in front of the spinal metastasis and other uptake in a rib and
in the skull. Planar acquisition (posterior view, Panel a), SPECT (Panel b) and fused (Panel c) images of SPECT/CT acquisition displaying the faint
RAI uptake in the left part of the skull are consistent with bone metastasis
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maxillary sinus. Hybrid CT scan evidenced a typical fea-
ture of aspergilloma with a dense soft-tissue mass in-
cluding a calcification, strongly suggesting a fungus ball
(Fig. 7). The patient also complained of a stuffy nose.
As WBS with SPECT/CT did not display malignant
RAI foci, 18 F-FDG PET/CT was performed and
evidenced FDG nodal uptake in the upper mediasti-
num. The patient was operated on in September 2014
with sternotomy to remove the FDG-avid lymph node.
Pathology confirmed malignancy. She then underwent
left sinus meatotomy endoscopically in February 2015
with removal of the fungus ball (Fig. 8). The stuffy nose
complaint disappeared after surgery. At the last visit in
April 2016, she was disease-free with a serum Tg level
at 0.5 ng/ml.
Discussion
This report describes five DTC patients in whom post-
RAI SPECT/CT acquisition revealed benign RAI uptake
in various sinuses (sphenoid, frontal or maxillary sinus)
related to mucosal thickening in four patients and to
aspergilloma in one. RAI sinus uptake has rarely been
reported in the literature. Using planar imaging in 1994,
Bakheet et al. reported frontal RAI uptake in a patient
with chronic sinusitis [1]. In 1997, also with planar im-
aging, Matheja et al. described frontal RAI uptake in a
patient with mucocele [2]. In a recent pictorial review
using SPECT/CT [8], Glazer et al. listed unusual physio-
logical RAI biodistributions at the head and neck level
but no sinus uptake SPECT/CT image was presented.
Our five case reports confirm the reality of sinus uptake
and demonstrate that such benign uptake is not uncom-
mon when SPECT/CT is routinely performed in com-
bination with WBS.
In Case 3, despite the lack of histopathologic confirm-
ation and the persistence of detectable Tg level without
identifiable structural lesion, we concluded that sinus
uptake was benign based on the pattern of RAI uptake
on WBS with SPECT/CT.
In four patients without any symptom of sinusitis,
incidental RAI uptake was due to sinus mucosal
thickening. The mechanism of RAI sinus uptake re-
mains elusive. As previously suggested [1], it might be
due to the accumulation of inflammatory nasal secre-
tions in the sinuses. As RAI is excreted in the salivary
glands and the nose, moderate uptake in the maxillary
Fig. 5 Planar acquisition (anterior view, Panel a), CT (Panel b) and fused (Panel c) images of SPECT/CT acquisition displaying RAI uptake in both
the right maxillary sinus (red arrow) and the left one (blue arrow) with bilateral mucosal thickening on CT scan slices
Fig. 6 WBS after RAI ablation in August 2008 (Panel a) and WBS
performed two days after the second RAI administration in June 2014
(Panel b) in the same female patient with increased serum Tg level. An
intense focal RAI uptake was observed in the left part of the face in
June 2014 (arrow) which was not present on the previous WBS
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and sphenoid sinuses can mimic physiological excre-
tion and might remain unknown on WBS. Interestingly,
RAI uptake was clearly related to aspergilloma in a maxil-
lary sinus in the fifth patient. To our knowledge, this is
the first such case to be reported although false-positive
lung RAI uptake due to aspergillosis has already been
documented [9–11]. Various fungi are known to be able
to take up iodine-125 [12]. RAI uptake might be due to
the presence of oxidants/antioxidants at sites of inflamma-
tion or to endotoxins or enzymes released by the fungus.
However, the exact mechanism of such an accumulation
in fungal cells remains unknown.
Thanks to its ability to localize RAI foci accurately on
hybrid low-dose CT scans, SPECT/CT imaging has con-
siderably altered the interpretation of planar scintigraphy
in the last ten years. The improvement due to SPECT/
CT is particularly significant when anatomical land-
marks are obviously lacking as on post-RAI scintigraphy.
Specifically, SPECT/CT was highly suggestive of asper-
gilloma on the hybrid CT scan without the need for
further examinations in Case 5.
Conclusions
In conclusion, false-positive RAI uptake in various sinuses
related to mucosal thickening and aspergilloma is possible
in patients with DTC and is well demonstrated by SPECT/
CT images. Nuclear medicine physicians should be
aware of such benign uptake when interpreting post-
RAI scintigraphy.
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Fig. 7 Complementary head and neck SPECT/CT was performed and confirmed that RAI uptake (fused images, Panels c & d) was located in the
left maxillary sinus (hybrid CT scan images, Panels a & b, blue arrow). Hybrid CT scan evidenced a typical feature of aspergilloma with a dense
soft-tissue mass including a calcification, suggesting a fungus ball
Fig. 8 The patient underwent left sinus meatotomy endoscopically
in February 2015 with removal of the fungus ball
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